Intuitive announced it intends to establish a direct presence in Italy, Spain, Portugal, Malta, and San Marino, and associated territories via the acquisition of the da Vinci and Ion distribution businesses in these countries. Intuitive has entered into this agreement, subject to regulatory approvals, with the current Intuitive technology distributors ab medica, Abex, Excelencia Robotica, and their affiliates to purchase their Intuitive product-related business. The transaction will not close until 2026, after approvals have been received and closing conditions met. Upon deal closure in 2026, the da Vinci and Ion business of ab medica, Abex, and Excelencia Robotica will be wholly owned by Intuitive, and business operations will be integrated into Intuitive’s European commercial and marketing organization, led by Senior Vice President and General Manager Dirk Barten. “Intuitive is excited to continue to invest in the significant opportunity to bring safe, minimally invasive care to more patients across Europe. Having a direct presence in Italy, Spain, Portugal, Malta, and San Marino, and associated territories allows us to deepen our understanding of unique customer needs in these countries,” said Intuitive CEO Gary Guthart.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $684 from $510 at Barclays
- Intuitive Surgical (ISRG) Q4 Earnings Cheat Sheet
- Options Volatility and Implied Earnings Moves This Week, January 21 – January 24, 2025
- Intuitive Surgical had ‘strong finish’ to 2024, says Morgan Stanley
- Early notable gainers among liquid option names on January 15th